[HTML][HTML] Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study …
EK Alidjinou, J Demaret, B Corroyer-Simovic… - The Lancet Regional …, 2022 - thelancet.com
Background The present study aimed to evaluate the persistent immunogenicity offered by a
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older …
EK Alidjinou, J Demaret… - The Lancet …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The present study aimed to evaluate the persistent immunogenicity offered by a
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
[HTML][HTML] Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study …
EK Alidjinou, J Demaret, B Corroyer-Simovic… - The Lancet Regional …, 2022 - Elsevier
Background The present study aimed to evaluate the persistent immunogenicity offered by a
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
[引用][C] Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in …
EK Alidjinou, J Demaret, B Corroyer-Simovic… - 2022 - lilloa.univ-lille.fr
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants
in nursing home residents: A prospective observational study in older adults aged from 68 to …
in nursing home residents: A prospective observational study in older adults aged from 68 to …
[引用][C] Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in …
EK Alidjinou, J Demaret, B Corroyer-Simovic… - The Lancet Regional …, 2022 - cir.nii.ac.jp
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron
variants in nursing home residents: A prospective observational study in older adults aged from …
variants in nursing home residents: A prospective observational study in older adults aged from …
[引用][C] Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in …
EK Alidjinou, J Demaret, B Corroyer-Simovic… - The Lancet Regional …, 2022 - hal.science
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants
in nursing home residents: A prospective observational study in older adults aged from 68 to …
in nursing home residents: A prospective observational study in older adults aged from 68 to …
[PDF][PDF] Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in …
EK Alidjinou, J Demaret, B Corroyer-Simovic… - Health, 2022 - researchgate.net
Background The present study aimed to evaluate the persistent immunogenicity offered by a
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older …
EK Alidjinou, J Demaret… - The Lancet Regional …, 2022 - europepmc.org
Background The present study aimed to evaluate the persistent immunogenicity offered by a
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
[HTML][HTML] Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study …
EK Alidjinou, J Demaret… - The Lancet Regional …, 2022 - ncbi.nlm.nih.gov
Background The present study aimed to evaluate the persistent immunogenicity offered by a
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older …
EK Alidjinou, J Demaret… - The Lancet Regional …, 2022 - europepmc.org
Background The present study aimed to evaluate the persistent immunogenicity offered by a
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …